Viracta Therapeutics, Inc.
VIRX · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $12 | $37 | $104 | $47 |
| Short-Term Investments | $41 | $54 | $0 | $0 |
| Receivables | $0 | $1 | $0 | $0 |
| Inventory | $0 | -$1 | $0 | $0 |
| Other Curr. Assets | $1 | $4 | $2 | $0 |
| Total Curr. Assets | $55 | $94 | $105 | $47 |
| Property Plant & Equip (Net) | $0 | $0 | $1 | $1 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $1 | $2 | $2 | $0 |
| Total NC Assets | $2 | $2 | $3 | $1 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $57 | $96 | $109 | $48 |
| Liabilities | – | – | – | – |
| Payables | $2 | $3 | $3 | $2 |
| Short-Term Debt | $26 | $1 | $0 | $1 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $10 | $7 | $6 | $3 |
| Total Curr. Liab. | $38 | $10 | $9 | $6 |
| LT Debt | $0 | $25 | $5 | $5 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $83 |
| Total NC Liab. | $0 | $25 | $5 | $88 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $1 | $1 |
| Total Liabilities | $38 | $35 | $14 | $95 |
| Equity | – | – | – | – |
| Pref Stock | $5 | $5 | $5 | $6 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$266 | -$215 | -$166 | -$51 |
| AOCI | $0 | -$0 | $0 | -$6 |
| Other Equity | $279 | $271 | $255 | $5 |
| Total Equity | $18 | $61 | $94 | -$46 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $57 | $96 | $109 | $48 |
| Net Debt | $13 | -$11 | -$98 | -$41 |